131

Brain gliocytoma and normal tissue array, including pathology grade, 40 cases/ 80 cores, replacing GL807

Brain glioma and normal tissue array, including pathology grade, 24 cases/72 cores, replacing GL722

Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores

Brain primary tumor high density (69 cases/208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue

Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases/208 cores

Brain tumor and normal tissue array with grade and TNM data, 40 cases/80 cores

Brain tumor and normal tissue array, 50 cases/100 cores

Brain tumor and normal tissue array, including pathology grade, 24 cases/72 cores

Brain tumor and normal tissue array, with pathology grade, 27 cases/81 cores, replacing BS17011

Brain tumor tissue array for antibody screening, 25 cases/100 cores

Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 12 cases/24 cores, replacing GL241a

Brain tumor tissue array with brain tissue, including pathology grade, 12 cases/24 cores, replacing T175a

Brain tumor tissue array, 40 cases/80 cores

Brain tumor tissue array, including pathology grade, 192 cases/192 cores, replacing GL2083b

Brain tumor tissue array, including pathology grade, 6 cases/24 cores

Brain tumor tissue array, including pathology grade, 96 cases/192 cores

Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replaced by GL2083b

Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replacing GL2083a

Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases/48 cores

Brain tumor tissue array, with normal tissue, 48 cases/48 cores

Brain tumor with adjacent normal brain tissue array, including pathology grade, 63 cases/63 cores, replacing BS17017a

Brain tumor with matched adjacent normal tissue array, including pathology grade, 80 cases/80 cores, replacing GL801

Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing BR1005a

Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases/100 cores, replacing BR10010e

Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, 104 cases/ 208 cores, replacing BR20837

Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, with ER, PR and Her-2 IHC results, 50 cases/100 cores, replacing BR10010d

Breast cancer and normal tissue array with stage and grade info, 40 cases/80 cores, replaced by BR8014

Breast cancer and normal tissue array, 16 cases/48 cores

Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases/96 cores

Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replaced by BR8015

Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases/96 cores

Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases/72 cores, replacing BS08011

Breast cancer array with adjacent normal breast tissue, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 110 cases/110 cores, replaced by BC081120c

Breast cancer array with adjacent normal breast tissue, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/110 cores, replacing BC081120c

Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores

Breast cancer Her-2 positive tissue array, including TNM, pathology grade and Her-2 markers, 75 cases/ 150 cores

Breast cancer issue array (screening of Her-2 positive samples), including TNM, clinical stage and pathology grade, 72 cases/ 72 cores

Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases/150 cores

Breast cancer mid-density tissue array, non-overlapping with either BRC1501 or BRC1503, 75 cases/150 cores

Breast cancer mid-density tissue array, non-overlapping with either BRC1502 or BRC1503, 75 cases/150 cores

Breast cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replaced by T087c

Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T086d

Breast cancer tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T089c

Breast cancer tissue array (all samples are from recent 4 years), including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, Ki67, 114 cases/ 114 cores.

Breast cancer tissue array (Her-2���3+/2+/1+/0), including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her-2 and Ki67), 4 cases/8 cores, replacing BR082d

Breast cancer tissue array (most of triple negative), 50 cases/150 cores

Breast cancer tissue array (most of triple negative), including TNM and pathology grade, with ER, PR and Her-2 IHC results, 60 cases/120 cores, replacing BR1202

Breast cancer tissue array (most of triple negative), including TNM, clinical stage and pathology grade,IHC markers (ER, PR, Her-2) results, 60 cases/120 cores

Breast cancer tissue array (most of triple negative), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 44 cases/88 cores

Breast cancer tissue array (most of triple negative), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201

Breast cancer tissue array (most of triple negative), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 95 cases/190 cores

Breast cancer tissue array (pathology grade 1-3), including TNM and clinical stage data, 45 cases/90 cores

Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases/72 cores

Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea/96 cores?replaced by BRM961a

Breast cancer tissue array for antibody screening , including TNM, clinical stage, pathology grade, and IHC markers (ER, PR, Her-2) results, 50 cases/100 cores

Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores

Breast cancer tissue array with adjacent breast tissue as control,, including pathology grade, TNM, clinical stage and IHC markers (ER, PR and Her-2), 110 cases/ 110 cores, replacing BC081116a

Breast cancer tissue array with adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b

Breast cancer tissue array with adjacent normal breast tissue, including TNM and pathology grade, 72 cases/72 cores, replacing BC08013b

Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BR8011

Breast cancer tissue array with adjacent normal breast tissue, including TNM, pathology grade, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replaced...

Breast cancer tissue array with cancer adjacent breast tissue as control, including TNM, clinical stage and pathology grade, 69 cases/ 207 cores, replaced by BR208b

Breast cancer tissue array with Her-2 IHC (0-3+) control, including TNM and pathology grade, Her-2 status, 4 cases/8 cores, replaced by BR082b

Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases/4 cores, replaced by BR042a

Breast cancer tissue array with lymph node positive and negative, including TNM, clinical stage and pathology grade, 98cases/ 110cores

Breast cancer tissue array with matched adjacent normal breast tissue, including TNM��� clinical stage and pathology grade, 6 cases/24 cores, replaced by BR251b

Breast cancer tissue array with matched cancer adjacent breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b

Breast cancer tissue array with normal tissue as control, including TNM and pathology grade, 24 cases/ 24 cores, replacing BR248

Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR483

Breast cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replacing T087b

Breast cancer tissue array with normal tissues from autopsy, 40 cases/80 cores, with TNM data

Breast cancer tissue array with normal tissues from autopsy, 80 cases/80 cores, with grade and stage data

Breast cancer tissue array, 102 cases/102 cores

Breast cancer tissue array, including pathology grade, IHC markers (ER, PR, Her-2) results, 4 cases/8 cores, replaced by BR082c

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR803a

Breast cancer tissue array, including pathology grade, TNM, clinical stage and IHC marker (Her-2/PR/ER), 4 cases/8 cores, replacing BR082b

Breast cancer tissue array, including TNM and pathology grade, 216 cases/216 cores

Breast cancer tissue array, including TNM and pathology grade, 50 cases/ 50 cores

Breast cancer tissue array, including TNM and pathology grade, IHC markers Her-2 results, 140 cases/140 cores

Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503e

Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503f

Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by BR246a

Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR484a

Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores

Breast cancer tissue array, including TNM, clinical stage and pathology grade, 49 cases/96 cores

Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, 75 cases/ 150 cores, replaced by BR1503e

Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases/208 cores, replacing BR2085a

Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/48 cores replacing BR247

Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM���clinical stage and IHC marker (ER, PR and Her-2), 189 cases/192 cores, replacing BR1921b

Breast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ER

Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a

Breast cancer, adjacent and adjacent normal tissue array, 66 cases/72 cores

Breast cancer, adjacent and adjacent normal tissue array, 68 cases/72 cores

Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 96 cases/100 cores, replacing BR1008

Breast cancer, matched metastatic carcinoma and cancer adjacent normal breast tissue array, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores,

Breast carcinoma (30 cases), infiltrating ductal carcinoma

Breast carcinoma (30 cases), mainly invasive ductal carcinoma.

Breast carcinoma (34 cases), infiltrating ductal carcinoma.